Financhill
Buy
60

REGN Quote, Financials, Valuation and Earnings

Last price:
$784.09
Seasonality move :
12.13%
Day range:
$777.00 - $792.75
52-week range:
$476.49 - $792.75
Dividend yield:
0.45%
P/E ratio:
18.80x
P/S ratio:
6.07x
P/B ratio:
2.67x
Volume:
832K
Avg. volume:
1.1M
1-year change:
9.79%
Market cap:
$82.5B
Revenue:
$14.2B
EPS (TTM):
$41.77

Regeneron Pharmaceuticals, Inc. SEC Filings

Company Filed Form Type Description
REGN
Regeneron Pharmaceuticals, Inc.
05/02/2024 10-Q 10-Q filing on 05/02/2024 View Form
REGN
Regeneron Pharmaceuticals, Inc.
11/02/2023 10-Q 10-Q filing on 11/02/2023 View Form
REGN
Regeneron Pharmaceuticals, Inc.
08/03/2023 10-Q 10-Q filing on 08/03/2023 View Form
REGN
Regeneron Pharmaceuticals, Inc.
05/04/2023 10-Q 10-Q filing on 05/04/2023 View Form
REGN
Regeneron Pharmaceuticals, Inc.
11/03/2022 10-Q 10-Q filing on 11/03/2022 View Form
REGN
Regeneron Pharmaceuticals, Inc.
08/03/2022 10-Q 10-Q filing on 08/03/2022 View Form
REGN
Regeneron Pharmaceuticals, Inc.
05/04/2022 10-Q 10-Q filing on 05/04/2022 View Form
REGN
Regeneron Pharmaceuticals, Inc.
11/04/2021 10-Q 10-Q filing on 11/04/2021 View Form
REGN
Regeneron Pharmaceuticals, Inc.
08/05/2021 10-Q 10-Q filing on 08/05/2021 View Form
REGN
Regeneron Pharmaceuticals, Inc.
05/06/2021 10-Q 10-Q filing on 05/06/2021 View Form
REGN
Regeneron Pharmaceuticals, Inc.
11/05/2020 10-Q 10-Q filing on 11/05/2020 View Form
REGN
Regeneron Pharmaceuticals, Inc.
08/05/2020 10-Q 10-Q filing on 08/05/2020 View Form
REGN
Regeneron Pharmaceuticals, Inc.
05/05/2020 10-Q 10-Q filing on 05/05/2020 View Form
REGN
Regeneron Pharmaceuticals, Inc.
02/07/2020 10-K 10-K filing on 02/07/2020 View Form
REGN
Regeneron Pharmaceuticals, Inc.
11/05/2019 10-Q 10-Q filing on 11/05/2019 View Form
REGN
Regeneron Pharmaceuticals, Inc.
08/06/2019 10-Q 10-Q filing on 08/06/2019 View Form
REGN
Regeneron Pharmaceuticals, Inc.
05/07/2019 10-Q 10-Q filing on 05/07/2019 View Form
REGN
Regeneron Pharmaceuticals, Inc.
02/07/2019 10-K 10-K filing on 02/07/2019 View Form
REGN
Regeneron Pharmaceuticals, Inc.
11/06/2018 10-Q 10-Q filing on 11/06/2018 View Form
REGN
Regeneron Pharmaceuticals, Inc.
08/02/2018 10-Q 10-Q filing on 08/02/2018 View Form
REGN
Regeneron Pharmaceuticals, Inc.
05/03/2018 10-Q 10-Q filing on 05/03/2018 View Form
REGN
Regeneron Pharmaceuticals, Inc.
02/08/2018 10-K 10-K filing on 02/08/2018 View Form
REGN
Regeneron Pharmaceuticals, Inc.
11/08/2017 10-Q 10-Q filing on 11/08/2017 View Form
REGN
Regeneron Pharmaceuticals, Inc.
08/03/2017 10-Q 10-Q filing on 08/03/2017 View Form
REGN
Regeneron Pharmaceuticals, Inc.
05/04/2017 10-Q 10-Q filing on 05/04/2017 View Form
REGN
Regeneron Pharmaceuticals, Inc.
02/09/2017 10-K 10-K filing on 02/09/2017 View Form
REGN
Regeneron Pharmaceuticals, Inc.
11/04/2016 10-Q 10-Q filing on 11/04/2016 View Form
REGN
Regeneron Pharmaceuticals, Inc.
08/04/2016 10-Q 10-Q filing on 08/04/2016 View Form
REGN
Regeneron Pharmaceuticals, Inc.
05/05/2016 10-Q 10-Q filing on 05/05/2016 View Form
REGN
Regeneron Pharmaceuticals, Inc.
02/11/2016 10-K 10-K filing on 02/11/2016 View Form

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 36x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
60
AAOI alert for Dec 24

Applied Optoelectronics, Inc. [AAOI] is up 5.1% over the past day.

Buy
85
HUT alert for Dec 24

Hut 8 Corp. [HUT] is up 0.65% over the past day.

Buy
63
GPCR alert for Dec 24

Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock